Drugs Exp Clin Res 1992;18(4):147-153
Potential signals of serious risks/new safety information identified by the FDA adverse event reporting system (FAERS)
A research article on evaluating the impact of tirepatide with nutrition and physical activity to maintain weight reduction
These cardiovascular effects suggest potential applications in ischemic heart disease, peripheral vascular disease, and vascular injury, though clinical translation requires confirmation of effects in human subjects
Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.IngredientsBPC 157 (L-Valine L-Glutamine L-Glycine L-Proline L-Lysine L-Alanine L-Arginine L-Histidine L-Leucine L-Tyrosine L-Serine L-Threonine L-Isoleucine L-Trypophan L-Methionine)BPC-159 (L-Valine L-Glutamine L-Glycine L-Proline L-Lysine L-Alanine L-Arginine L-Histidine L-Leucine L-Tyrosine L-Serine L-Threonine L-Isoleucine L-Tryptophan L-Methionine) Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition